DSM BioSolutions: (Bio-) Pharmaceuticals by microbial fermentation
By 2015, eight of the top 10-selling drugs will be a biopharmaceutical protein. A major part of these novel drugs can be produced most efficiently by microbial fermentation.
Meanwhile, also small molecule pharmaceuticals are receiving renewed interest in the treatment of e.g. resilient infectious diseases. Novel molecules often are produced by fermentation with follow-on chemical modification.
The future looks fermentation-based, and if you need a proven contract manufacturer to help capitalize on the wealth of emerging new opportunities ...look no further than DSM.
We have 100 years of experience in microbial fermentation, producing a variety of product classes. Our bright science comes from a proven blend of technologies, processes – and of course- people.
Whatever the project, capacity or timelines, we can help you get your product to clinic and market faster and more efficiently.Whatever the project, capacity or timescales, we can help you get your product to market fast and more efficiently.
DSM proposes appointment of new Chief Financial Officer
10 Mar 2014 07:00 CET
DSM – repurchase of shares (27 February – 6 March 2014)
07 Mar 2014 09:15 CET
DSM wins ‘Breakthrough Technology of the Year’
06 Mar 2014 10:30 CET